No evidence of association between PTSD, cancer risk
the ONA take:
According to a new study published in the European Journal of Epidemiology, researchers from Boston University School of Medicine in Boston, Massachusetts, have found that post-traumatic stress disorder (PTSD) is not a risk factor for developing cancer.
For the study, researchers included all Danish-born residents of Denmark from 1995 to 2011. During that time, PTSD was diagnosed in 4,131 people.
Researchers included all malignant neoplasms, hematologic malignancies, immune-related cancers, smoking- and alcohol-related cancers, and cancers at all other sites as main outcomes. Results showed that there were no associations between PTSD and nearly all cancer diagnoses examined.
This study is the largest study to date evaluating PTSD as a predictor of various cancer types. The large sample size and long study duration allowed researchers to examine associations that had previously not been analyzed.
Post-traumatic stress disorder is not a risk factor for developing cancer.
Sign Up for Free e-newsletters
- Incidence of Post-traumatic Stress Disorder High Among Patients With Cancer
- Long-Term Night Shift Work Associated With Cancer Risk in Women
- Distress, Neuroticism Predict Long-term Emotional Distress After Cancer Diagnosis
- Dietary Estrogens Reduced Efficacy of Novel Breast Cancer Therapy
- FDA Grants Breakthrough Therapy Designation to Lenvatinib Plus Pembrolizumab for RCC
- Bacteria in Probiotics Carry Potential Risks for Immunocompromised Patients
- Pertuzumab Regimen Approved for Adjuvant, Neoadjuvant Therapy in Specific Breast Cancers
- Common Oncologic Emergencies That Occur With Multiple Myeloma
- Artificial Sweeteners and Cancer Risk (Fact Sheet)
- Blueberry Extract May Boost Efficacy of Radiotherapy for Cervical Cancer
- FDA Issues Warning for Rolapitant Injectable Emulsion in the Treatment of CINV
- Risk Factors for Arterial, Venous Thrombosis Differ in Polycythemia Vera
- Breast Cancer Deaths Decrease Sharply Since 2000
- Identifying the Psychosocial Needs of Young Adults With Metastatic Cancer
- BRCA Mutation Improves Prognosis for 2-year Survival in Younger-onset TNBC
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|